MAPT and Alzheimer disease: The fully treated and stained control wells with unseeded cells were critical controls to evaluate specificity of all primary antibodies, backgrounds in PLD-coated plates and to control for residual autofluorescence of lipofuscin or other compounds [78–81] present in the AD brain-derived tau inoculum (Additional file 1: Fig S3A).